QLT is a biotechnology company dedicated to the development and commercialization of ocular products.
Dr. Anido previously served as president, CEO and a director of Ista Pharmaceuticals, which was recently acquired by Bausch & Lomb.
Prior to this position, Dr. Anido held positions with Windamere Venture Partners, CombiChem and the Americas Region of Allergan.
QLT is headquartered in Vancouver, Canada.
Related Articles on Ophthalmology:
Miami’s Bascom Palmer Eye Institute Ranked #1 Ophthalmology Program by U.S. News
Ophthalmologist William De La Peña to Serve on UCSF Advisory Board
tudy: Risk for Retinal Detachment After Phacoemulsification Declines
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
